New Wegovy Prices in the UK: the Honest Picture

Why have Wegovy prices changed recently?

The short answer: supply has stabilised and the market has matured since Wegovy launched in the UK. Early shortages pushed private prices up; as stock normalised, pricing across providers began to settle. That said, Wegovy is still a Black Triangle medicine under additional MHRA monitoring, and the cost of legitimate dispensing (proper cold-chain storage, licensed supply, GPhC-regulated pharmacy infrastructure) doesn't disappear when competition increases.

It's also worth knowing that Novo Nordisk, the manufacturer, introduced a dedicated single-dose 7.2mg pen in April 2026 after MHRA approval. That higher-dose option is newer and can sit at a different price point from the standard 2.4mg maintenance pens. The dose you're on matters as much as the provider you're with when comparing monthly costs, and our dose-by-dose price breakdown covers that in more detail.

For context: NICE's recommendation for semaglutide (TA875) sets out strict eligibility criteria for NHS access, including a maximum treatment duration of two years within a specialist service. That means most people seeking Wegovy do so privately, which is why private pricing is what most readers are actually researching. If you want to understand how the Wegovy new price compares to what was being charged when supply was tighter, that page sets out what has shifted and why. You can read the NICE TA875 recommendation for the full NHS eligibility picture.

What do headline Wegovy prices typically leave out?

A quoted price is only as honest as what sits beneath it. Across the private market, some providers charge separately for the initial consultation, the prescription itself, or for any clinical follow-up between doses. Delivery costs are also commonly added at checkout, sometimes for every order, not just the first. When you're comparing figures across providers, it's worth building the full monthly number: treatment plus consultation plus prescription plus delivery plus any ongoing aftercare.

Aftercare is the piece most people don't think about until they need it. GLP-1 medicines like Wegovy can cause nausea, digestive discomfort and other side effects, particularly in the first weeks or after a dose increase. Being able to reach a prescriber without an extra charge is a practical thing, not a luxury. The NHS semaglutide patient information page gives a fair overview of what to expect, and knowing you have clinical support on hand if something feels off matters.

Transfer patients (people moving from another provider mid-course) sometimes find that a new pharmacy charges a separate assessment fee on top. Worth checking before you switch. Our guide to Wegovy pen pricing goes through how the numbers stack up across a typical treatment course.

How does nume price Wegovy, and why isn't it the cheapest?

We're not going to win a price-comparison race, and that's a deliberate call. One transparent price covers consultation, prescription, dispensing, next-working-day DPD delivery and 7-day aftercare, no separate fees, no subscription that quietly renews, no add-ons at checkout. Every repeat order gets a fresh clinical review before it goes out. We're GPhC-registered (premises number 9012878, verifiable at the GPhC pharmacy register), and every consultation is personally reviewed by a GPhC-registered Independent Prescriber the same day, not filtered through an algorithm first.

The honest price for treatment is on our treatment page. We don't print per-pen prices in editorial copy, because a number without context (without the prescription, delivery and aftercare it does or doesn't include) isn't really a price. It's a starting point for a longer bill.

If you're weighing up your options and want to understand the team behind the clinical decisions, our clinical lead's profile sets out the approach. And if you have questions before starting, the FAQs cover the things people ask most often.

Is cheapest the right question to ask about a prescription medicine?

Probably not. Wegovy is a prescription-only medicine, meaning legally it can only reach you after a clinician has assessed your suitability. The MHRA has issued repeated warnings about fake weight-loss pens sold online, and in 2025 enforcement teams seized roughly 20 million doses of illegally traded medicines worth an estimated £45 million, including the first illicit UK manufacturing site producing counterfeit tirzepatide pens. Fake pens have been found to contain insulin rather than the medicine on the label. That's not a fringe risk.

A lower quoted price from an unverified seller is a red flag, not a bargain. Any legitimate provider should be findable on the GPhC register; any legitimate prescription must follow a genuine clinical assessment. Patients starting on the lowest injection amount can find a full breakdown of what to expect on our Wegovy 1mg prices page, which explains how costs typically progress as doses increase. You can also report suspect sellers through the MHRA Yellow Card scheme. The right metric for a prescription medicine isn't the smallest number, it's whether the supply chain is licensed, the clinical oversight is real and the pharmacy is accountable. Speak to our prescribers if you'd like a straightforward assessment of whether Wegovy is clinically suitable for you.